No Proof Of Big Payment, AstraZeneca Says At Nexium Trial
AstraZeneca PLC urged a Massachusetts federal judge to award it judgment on all claims made by plaintiffs in a pay-for-delay trial over the heartburn drug Nexium, saying Tuesday that no reasonable...To view the full article, register now.
Already a subscriber? Click here to view full article